IFP Advisors
ENTA icon

IFP Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History

IFP Advisors’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.27K Sell
400
-2
-0.5% -$27 ﹤0.01% 3787
2026
Q2 		$5.86K Buy
402
+6
+2% +$81 ﹤0.01% 3689
2026
Q1 		$5K Hold
396
– – ﹤0.01% 3528
2025
Q4 		$6.24K Hold
396
– – ﹤0.01% 3307
2025
Q3 		$4.74K Buy
396
+11
+3% +$88 ﹤0.01% 3286
2025
Q2 		$3.08K Buy
+385
New +$2.32K ﹤0.01% 3683
2025
Q1 		– Sell
-3
Closed -$17 – 4402
2024
Q4 		$17 Buy
+3
New +$29 ﹤0.01% 4475
2020
Q4 		– Sell
-259
Closed -$11.4K – 2987
2020
Q3 		$11K Buy
+259
New +$12.5K ﹤0.01% 1864
2018
Q4 		– Sell
-136
Closed -$12K – 3615
2018
Q3 		$12K Hold
136
– – ﹤0.01% 2739
2018
Q2 		$16K Hold
136
– – ﹤0.01% 2597
2018
Q1 		$8K Hold
136
– – ﹤0.01% 2912
2017
Q4 		$8K Hold
136
– – ﹤0.01% 2957
2017
Q3 		$6K Hold
136
– – ﹤0.01% 3291
2017
Q2 		$5K Hold
136
– – ﹤0.01% 3383
2017
Q1 		$4K Sell
136
-175
-56% -$5.45K ﹤0.01% 3400
2016
Q4 		$10K Buy
311
+136
+78% +$3.9K ﹤0.01% 2889
2016
Q3 		$5K Sell
175
-1,476
-89% -$34.3K ﹤0.01% 3215
2016
Q2 		$36K Buy
+1,651
New +$43.2K ﹤0.01% 1966
2016
Q1 		– Sell
-1,714
Closed -$57K – 2654
2015
Q4 		$57K Buy
+1,714
New +$55.9K ﹤0.01% 1524

Other funds holding ENTA

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Versant Capital Management
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
True Wealth Design
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
Essential Partners
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Fortitude Family Office
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

IFP Advisors's ENTA Position: Q3 2026 in Review

IFP Advisors reduced its Enanta Pharmaceuticals (ENTA) stake by 0.5% in Q3 2026, selling an estimated $27 and leaving 400 shares worth $5.27K. The position accounts for ﹤0.01% of the portfolio, ranked #3787.

IFP Advisors first reported a position in ENTA in Q4 2015 and has held it in 19 quarters since. The position peaked at $57K in Q4 2015. 9 funds tracked by Wall St. Rank hold ENTA as of Q3 2026.

  • IFP Advisors held 400 shares of Enanta Pharmaceuticals worth $5.27K as of Q3 2026.
  • IFP Advisors sold 2 Enanta Pharmaceuticals shares in Q3 2026, an estimated $27.
  • Enanta Pharmaceuticals made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #3787 holding.
  • IFP Advisors first reported a position in Enanta Pharmaceuticals in Q4 2015 and has held it in 19 quarters since.
  • IFP Advisors's Enanta Pharmaceuticals position peaked at $57K in Q4 2015.
  • 9 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.